How temporal patterns of medication adherence to antidepressants, bisphosphonates and statins are associated with healthcare cost

[1]  H. Cutler,et al.  A systematic review and meta-analysis on impact of suboptimal use of antidepressants, bisphosphonates, and statins on healthcare resource utilisation and healthcare cost , 2022, PloS one.

[2]  H. Cutler,et al.  Identifying temporal patterns of adherence to antidepressants, bisphosphonates and statins, and associated patient factors , 2021, SSM - population health.

[3]  L. Parkin,et al.  Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users , 2020, PloS one.

[4]  D. Holdford,et al.  Medication Adherence Trajectories: A Systematic Literature Review , 2020, Journal of managed care & specialty pharmacy.

[5]  L. Schwettmann,et al.  Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data , 2020, BMC Health Services Research.

[6]  K. Bennett,et al.  Longitudinal Medication Adherence in Older Adults With Multimorbidity and Association With Health Care Utilization: Results From the Irish Longitudinal Study on Ageing , 2020, The Annals of pharmacotherapy.

[7]  H. Xiang,et al.  Perceived health after adult traumatic brain injury: a Group-Based Trajectory Modeling (GBTM) analysis , 2020, Brain injury.

[8]  A. Rezapour,et al.  Economic burden of osteoporosis in the world: A systematic review , 2020, Medical journal of the Islamic Republic of Iran.

[9]  T. Egberts,et al.  Discontinuation Rates of Antidepressant Use by Dutch Soldiers. , 2019, Military medicine.

[10]  Susan M. Smith,et al.  The association between pharmacy refill‐adherence metrics and healthcare utilisation: a prospective cohort study of older hypertensive adults , 2019, The International journal of pharmacy practice.

[11]  Hsien-Wei Ting,et al.  Exploration of Medical Trajectories of Stroke Patients Based on Group-Based Trajectory Modeling , 2019, International journal of environmental research and public health.

[12]  A. Pottegård,et al.  Statins in Older Danes: Factors Associated With Discontinuation Over the First 4 Years of Use , 2019, Journal of the American Geriatrics Society.

[13]  Philip Smith,et al.  Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review , 2019, BMJ Open.

[14]  N. Freemantle,et al.  Factors associated with discontinuation of antidepressant treatment after a single prescription among patients aged 55 or over: evidence from English primary care , 2019, Social Psychiatry and Psychiatric Epidemiology.

[15]  D. Symmons,et al.  Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease , 2019, PloS one.

[16]  I. Kawachi,et al.  Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus , 2019, Arthritis care & research.

[17]  T. Peters,et al.  Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. , 2018, Health technology assessment.

[18]  J. Shafrin,et al.  Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical Illnesses , 2018, Advances in Therapy.

[19]  Alessandro Gasparini,et al.  comorbidity: An R package for computing comorbidity scores , 2018, J. Open Source Softw..

[20]  Susan M. Smith,et al.  Group‐Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting , 2017, Clinical pharmacology and therapeutics.

[21]  S. Parrott,et al.  Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta‐analysis , 2017, Research in social & administrative pharmacy : RSAP.

[22]  E. Okuyan,et al.  Assessment of factors related to statin non-adherence in patients with established coronary artery disease: A single-center observational study. , 2017, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[23]  J. Steiner,et al.  The myths of medication adherence , 2017, Pharmacoepidemiology and drug safety.

[24]  M. Eaddy,et al.  Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder , 2017, Current medical research and opinion.

[25]  V. Conn,et al.  Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. , 2017, Preventive medicine.

[26]  D. Giedrimienė,et al.  Abstract 207: Burden of Cardiovascular Disease (CVD) on Economic Cost. Comparison of Outcomes in US and Europe , 2017 .

[27]  J. Kleijnen,et al.  A systematic review to assess adherence and persistence with statins , 2017, Current medical research and opinion.

[28]  J. Lindenmayer,et al.  Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia , 2016, Journal of managed care & specialty pharmacy.

[29]  Y. Kwan,et al.  Systematic review of the barriers affecting medication adherence in older adults , 2016, Geriatrics & gerontology international.

[30]  P. Vestergaard,et al.  Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries , 2016, Osteoporosis International.

[31]  S. Perera,et al.  Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program , 2016, Journal of General Internal Medicine.

[32]  Siew Ching Ho,et al.  Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review. , 2016, Journal of affective disorders.

[33]  H. Placzek,et al.  Cost and consequences of noncompliance to oral bisphosphonate treatment. , 2015, Journal of managed care & specialty pharmacy.

[34]  Paula Fresco,et al.  Medication Adherence Measures: An Overview , 2015, BioMed research international.

[35]  Ying-Chun Li,et al.  Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study , 2015, BioMed research international.

[36]  T. Brennan,et al.  Association between trajectories of statin adherence and subsequent cardiovascular events , 2015, Pharmacoepidemiology and drug safety.

[37]  Olga V. Patterson,et al.  Analysis of osteoporosis treatment patterns with bisphosphonates and outcomes among postmenopausal veterans. , 2015, Bone.

[38]  E. Banks,et al.  The crux of the matter: Did the ABC's Catalyst program change statin use in Australia? , 2015, The Medical journal of Australia.

[39]  P. Geusens,et al.  Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study , 2015, Osteoporosis International.

[40]  Benoit Liquet,et al.  Estimation of extended mixed models using latent classes and latent processes: the R package lcmm , 2015, 1503.00890.

[41]  Martin T. Wells,et al.  Addressing the Zeros Problem: Regression Models for Outcomes with a Large Proportion of Zeros, with an Application to Trial Outcomes , 2015 .

[42]  C. Bertram,et al.  Associations Between Statin Adherence Level, Health Care Costs, and Utilization , 2014, Journal of managed care & specialty pharmacy.

[43]  D. Nagin.  Group-Based Trajectory Modeling: An Overview , 2014, Annals of Nutrition and Metabolism.

[44]  A. Rung,et al.  Medication Adherence in Older Adults: A Qualitative Study , 2014, Educational gerontology.

[45]  N. Rice,et al.  Applied Health Economics - second edition , 2013 .

[46]  J. Gallacher,et al.  Why representativeness should be avoided. , 2013, International journal of epidemiology.

[47]  D. Berbiche,et al.  Association Between Depressive and Anxiety Disorders and Adherence to Antihypertensive Medication in Community‐Living Elderly Adults , 2012, Journal of the American Geriatrics Society.

[48]  Daniel S. Nagin,et al.  A Note on a Stata Plugin for Estimating Group-based Trajectory Models , 2012 .

[49]  J. Rausch,et al.  Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. , 2011, JAMA.

[50]  R. Simpson,et al.  The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. , 2010, Journal of clinical lipidology.

[51]  P. Muntner,et al.  Association of Depression with Antihypertensive Medication Adherence in Older Adults: Cross-Sectional and Longitudinal Findings from CoSMO , 2010, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[52]  K. Langa,et al.  Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach. , 2010, Value in Health.

[53]  David G Steel,et al.  Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs , 2010, BMC medical research methodology.

[54]  Daniel S Nagin,et al.  Group-based trajectory modeling in clinical research. , 2010, Annual review of clinical psychology.

[55]  G. Mancia,et al.  Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. , 2010, Clinical therapeutics.

[56]  I. Imaz,et al.  Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis , 2010, Osteoporosis International.

[57]  M. Tournier,et al.  Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population. , 2009, Journal of affective disorders.

[58]  V. Beral,et al.  Cohort Profile: The 45 and Up Study , 2007, International journal of epidemiology.

[59]  J. Benner,et al.  Predictors of Adherence to Concomitant Antihypertensive and Lipid-Lowering Medications in Older Adults , 2008, Drugs & aging.

[60]  S. Andrade,et al.  Consequences of poor compliance with bisphosphonates. , 2007, Bone.

[61]  Femida Gwadry-Sridhar,et al.  A checklist for medication compliance and persistence studies using retrospective databases. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[62]  R. Obenchain,et al.  Higher Costs and Therapeutic Factors Associated With Adherence to NCQA HEDIS Antidepressant Medication Management Measures: Analysis of Administrative Claims , 2006, Journal of managed care pharmacy : JMCP.

[63]  W. Katon,et al.  Impact of antidepressant drug adherence on comorbid medication use and resource utilization. , 2005, Archives of internal medicine.

[64]  B. Druss,et al.  Relationship of Total Health Care Charges to Selective Serotonin Reuptake Inhibitor Utilization Patterns Including the Length of Antidepressant Therapy Results From a Managed Care Administrative Claims Database , 2005, Journal of managed care pharmacy : JMCP.

[65]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[66]  A. Rush,et al.  Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. , 1998, Archives of general psychiatry.

[67]  R. Park.  Estimation with Heteroscedastic Error Terms , 1966 .